Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Jun;64(6):1708-12.
doi: 10.1002/art.34445.

Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunity

Kevin D Deane
Editorial

Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunity

Kevin D Deane. Arthritis Rheum. 2012 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phases of development of rheumatoid arthritis (RA). In this model of RA development, disease begins with genetic risk (phase 1), followed by asymptomatic inflammation and autoimmunity (phase 2), with eventual progression to symptomatic inflammatory arthritis (IA) (phase 3) that may progress to classifiable RA (phase 4). Currently, the asymptomatic phases of disease development (phases 1 and 2) can be termed the “preclinical” period of development, although this nomenclature is in evolution. Not all subjects who are at risk of developing RA progress through all of these phases, and some subjects may have resolution of inflammation, autoimmunity, and even inflammatory arthritis (demonstrated by the bidirectional arrows). The mechanisms of transition between these phases are not well understood but likely involve complex relationships between genetic and environmental factors (which may differ between phases), age-related and stochastic immunologic changes, as well as psychosocial factors, access to health care, and response to therapy.
See this image and copyright information in PMC

Comment on

References

    1. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum. 1988;31:1239–44. - PubMed
    1. Silman AJ, Hennessy E, Ollier B. Incidence of rheumatoid arthritis in a genetically predisposed population. Br J Rheumatol. 1992;31:365–8. - PubMed
    1. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol. 1991;18:1282–4. - PubMed
    1. Aho K, Palosuo T, Heliovaara M, Knekt P, Alha P, von Essen R. Antifilaggrin antibodies within “normal” range predict rheumatoid arthritis in a linear fashion. J Rheumatol. 2000;27:2743–6. - PubMed
    1. Aho K, Palosuo T, Knekt P, Alha P, Aromaa A, Heliovaara M. Serum C-reactive protein does not predict rheumatoid arthritis. J Rheumatol. 2000;27:1136–8. - PubMed

Publication types